Study: Common painkillers tied to lower skin cancer risk

By REUTERS
May 30, 2012 05:17

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

People who had taken aspirin, ibuprofen and related painkillers - especially at high doses and for years at a time - were less likely to get skin cancer compared to those who rarely used those medications, according to a study from Denmark.

The findings, which looked at records from more than 18,000 people from Denmark and were published in the peer-reviewed journal Cancer, add to growing evidence that long-term use of the medications, known as nonsteroidal anti-inflammatory drugs (NSAIDS), may help protect people against skin cancer, including melanoma, the deadliest.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Breaking news
October 17, 2018
Special envoy to Syria to resign from U.N.

By REUTERS